Skip to content

FDA decisions.

Of 187 FDA decisions for US-listed companies since 2011, 67% were approvals.

67%approved
  • Approved67%
  • Rejected (complete response letter)33%

Based on 187 cases.

Method

How this is measured

FDA decision dates that companies announced, matched to the outcome: an approval in FDA's records or a complete response letter the company reported. Only decided cases count; a date that passed with no decision on record is left out. Measured on Steady's price history, which holds only companies still trading, so companies that later failed are missing and the picture is kinder than it was. A pattern across many companies says little about any one company.

Steady publishes these figures for information only. Nothing here is investment advice.